Cargando…
Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group
Between 2008 and 2019, 58,914 hematopoietic stem cell transplantations (HSCTs) were reported to the Chinese Blood and Marrow Transplantation Registry Group (CBMTRG) throughout China. In this report, we focus on 2019 data and describe current trends in HSCT in China. There was continued growth in tra...
Autores principales: | Xu, Lan-Ping, Lu, Pei-Hua, Wu, De-Pei, Sun, Zi-Min, Liu, Qi-Fa, Han, Ming-Zhe, Zhang, Xi, Song, Yong-Ping, Song, Xian-Min, Hu, Jian-da, Huang, He, Lai, Yong-Rong, Wan, Ding-Ming, Chen, Jing, Li, Chun-Fu, Xia, Ling-Hui, Wang, Jing-Bo, Liu, Dai-Hong, Huang, Xiao-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385702/ https://www.ncbi.nlm.nih.gov/pubmed/34433917 http://dx.doi.org/10.1038/s41409-021-01431-6 |
Ejemplares similares
-
Hematopoietic Stem Cell Transplantation Activity in China 2020–2021 During the SARS-CoV-2 Pandemic: A Report From the Chinese Blood and Marrow Transplantation Registry Group
por: Xu, Lan-Ping, et al.
Publicado: (2023) -
The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update
por: Zhang, Xiao-hui, et al.
Publicado: (2021) -
Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant
por: Xu, Lan-Ping, et al.
Publicado: (2017) -
Outcomes of Different Haploidentical Transplantation Strategies from the Taiwan Blood and Marrow Transplantation Registry
por: Tsai, Xavier Cheng-Hong, et al.
Publicado: (2022) -
Comparison of outcomes after human leukocyte antigen-matched and haploidentical hematopoietic stem-cell transplantation for multiple myeloma
por: Chen, Yao, et al.
Publicado: (2019)